BOIMMG

1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

BOIMMG ID - 264699

Name - 1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - BFDVGJWFVAKWAY-OJUQJJAVSA-G

Formula - C61H101O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000440177

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C61H102O19P3	289042	✔
1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C61H103O16P2	275122	✔
1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C61H104O13P	11286	✔
CDP-1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycerol	C64H105N3O15P2	551748	✔
1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C61H103O16P2	265932	✔
1-(13Z,16Z-docosadienoyl)-2-(15Z,18Z,21Z,24Z,27Z-triacontapentaenoyl)-sn-glycero-3-phosphate	C55H93O8P	18618	✔
Acyl-ACP ((15Z,18Z,21Z,24Z,27Z)-triacontapentaenoate)	C30H49OSR1	749013	✗
1-(13Z,16Z-docosadienoyl)-sn-glycero-3-phosphate	C25H45O7P	6815	✔
(15Z,18Z,21Z,24Z,27Z)-triacontapentaenoyl-CoA	C51H80N7O17P3S	362	✔
Acyl-ACP ((13Z,16Z)-docosadienoate)	C22H39OSR1	749032	✗
Acyl-Phosphates ((13Z,16Z)-docosadienoate)	C22H41O5P	738855	✗